Evidence map›Paper›PMID 21726630›Full record

ArticleCellular signalling2011

Nuclear presence of nuclear factor of activated T cells (NFAT) c3 and c4 is required for Toll-like receptor-activated innate inflammatory response of monocytes/macrophages.

Hiroshi Minematsu, Mike J Shin, Ayse B Celil Aydemir, Kyung-Ok Kim, Saqib A Nizami, Gook-Jin Chung, Francis Young-In Lee

Open access · greenAbstract read
In one paragraph

Article in Cellular signalling, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Unlocking the therapeutic potential of the NFAT pathway in kidney diseases.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Identification of MicroRNAs RegulatingCurrent issues in molecular biology · 2023
    Article
  9. Article
  10. Review
  11. Article
  12. Diabetic Kinome Inhibitors-A New Opportunity for β-Cells Restoration.International journal of molecular sciences · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hiroshi MinematsuCenter for Orthopaedic Research, Department of Orthopaedic Surgery, Columbia University, 650 West 168th Street BB14-1412, New York, NY 10032, USA.
Mike J Shin
Ayse B Celil Aydemir
Kyung-Ok Kim
Saqib A Nizami
Gook-Jin Chung
Francis Young-In Lee
Center for Orthopaedics · USColumbia University · US

Funding

ERK Signaling in Inflammatory Bone LossR01AR056246 · NIAMS · YALE UNIVERSITY · PI LEE, FRANCIS YOUNG-IN · 2009 to 2018
$3.5M
Mechanobiological Mechanism for Inflammatory Bone LossR01EB006834 · NIBIB · YALE UNIVERSITY · PI LEE, FRANCIS YOUNG-IN · 2007 to 2015
$2.6M
NIAMS NIH HHS R01 AR056246NIAMS NIH HHS R01AR056246NIBIB NIH HHS R01 EB006834NIBIB NIH HHS R01EB006834
6 · The paper itself

Abstract

Nuclear factor of activated T cells (NFATs) are crucial transcription factors that tightly control proinflammatory cytokine expression for adaptive immunity in T and B lymphocytes. However, little is known about the role of NFATs for innate immunity in macrophages. In this study, we report that NFAT is required for Toll-like receptor (TLR)-initiated innate immune responses in bone marrow-derived macrophages (BMMs). All TLR ligand stimulation including LPS, a TLR4 ligand, and Pam(3)CSK(4), a TLR1/2 ligand, induced expression of TNF which was inhibited by VIVIT, an NFAT-specific inhibitor peptide. BMMs from NFATc4 knock-out mouse expressed less TNF than wild type. Despite apparent association between NFAT and TNF, LPS did not directly activate NFAT based on NFAT-luciferase reporter assay, whereas NF-κB was inducibly activated by LPS. Instead, macrophage exhibited constitutive NFAT activity which was not increased by LPS and was decreased by VIVIT. Immunocytochemical examination of NFATc1-4 of BMMs exhibited nuclear localization of NFATc3/c4 regardless of LPS stimulation. LPS stimulation did not cause nuclear translocation of NFATc1/c2. Treatment with VIVIT resulted in nuclear export of NFATc3/c4 and inhibited TLR-activated TNF expression, suggesting that nuclear residence of NFATc is required for TLR-related innate immune response. Chromatin immunoprecipitation (ChIP) assay using anti-RNA polymerase II (PolII) antibody suggested that VIVIT decreased PolII binding to TNF gene locus, consistent with VIVIT inhibition of LPS-induced TNF mRNA expression. This study identifies a novel paradigm of innate immune regulation rendered by NFAT which is a well known family of adaptive immune regulatory proteins.

Indexed as

Immunity, InnateAnimalsBone MarrowCell NucleusChromatin ImmunoprecipitationCytokinesHumansImmunohistochemistryLipopeptidesLipopolysaccharidesMacrophagesMiceMice, KnockoutMonocytesNFATC Transcription FactorsNF-kappa BCytokinesLipopeptidesLipopolysaccharidesNFATC Transcription FactorsNF-kappa BOligopeptidesPam(3)CSK(4) peptideRNA, MessengerRNA Polymerase IIToll-Like Receptorstranscription factor NF-AT c3Tumor Necrosis Factor-alphaVIVIT peptide

Identifiers

PMID21726630
PMCPMC3169434
OpenAlexW2027012270

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.